Publisher Summary This chapter provides a review of the clinical evidence for the value of
pharmacotherapy and other measures, such as surgical decompression for the treatment of …

Approximately 11,000 people will experience a spinal cord injury in the United States each
year, with over half of those between the ages of 16 and 30 years. An estimated 183,000 to …

Spinal cord injury (SCI) causes significant morbidity and mortality leading to serious social
problems. Although many studies conducted on it, any universal treatment protocol has not …

Therecently published results of the National Acute Spinal Cord Injury Study (NASCIS II)
have complicated studies of acute spinal cord injury treatments in several ways. First …

Therapeutic intervention and rehabilitation after spinal cord injury (SCI) are currently
confronted with tremendous challenges in basic and clinical medicine. The pathological …

Objectives: To evaluate the safety and effect on neurological outcome of nimodipine,
methylprednisolone, or both versus no medical treatment in spinal-cord injury during the …

414 WIMP June 1997-Vol 166, No. 6 Epitomes-Neurosurgery ond noncontiguous fracture
exists. Screening evaluation of the entire axis from occiput to sacrum is necessary and …

Context Current treatment of spinal cord injury (SCI) focuses on cord stabilization to prevent
further injury, rehabilitation, management of non-motor symptoms, and prevention of …

Pharmacological Neuroprotective Therapy for Acute Spinal Cord Injury: State of the Art Page 1
222 Mini-Reviews in Medicinal Chemistry, 2008, 8, 222-230 1389-5575/08 $55.00+.00 © 2008 …

There are no drugs specifically approved for spinal cord injury that directly address the
underlying damage to neural tissue. Immediate treatment with methylprednisolone sodium …